Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
40,013,592
-
Share change
-
+6,307,209
-
Total reported value
-
$133,633,107
-
Put/Call ratio
-
0%
-
Price per share
-
$3.34
-
Number of holders
-
59
-
Value change
-
+$27,002,831
-
Number of buys
-
31
-
Number of sells
-
39
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2014
As of 30 Jun 2014,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,013,592 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, Ghost Tree Capital, LLC, D. E. Shaw & Co., Inc., FMR LLC, and BAKER BROS. ADVISORS LP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.